RESUMEN
Bandgap tunable lanthanum niobium oxynitride [LaNb2 O7-x Nx ](1+x)- nanosheet is prepared by the delamination of a Ruddlesden-Popper phase perovskite oxynitride via ion-exchange and two-step intercalation processes. The lanthanum niobium oxynitride nanosheets have a homogeneous thickness of 1.6 nm and exhibit a variety of chromatic colors depending on the nitridation temperature of the parent-layered oxynitride. The bandgap energy of the nanosheets is determined by ultraviolet photoemission spectroscopy, Mott-Schottky, and photoelectrochemical measurements and is found to be tunable in the range of 2.03-2.63 eV. Furthermore, the oxide/oxynitride superlattice structures are fabricated by face-to-face stacking of 2D crystals using oxynitride [LaNb2 O7-x Nx ](1+x)- and oxide [Ca2 Nb3 O10 ]- nanosheets as building blocks. Moreover, the superlattices-like restacked oxynitride/oxide nanosheets hybrid exhibits unique proton conductivity and dielectric properties strongly influenced by the oxynitride nanosheets and enhanced photocatalytic activity under visible light irradiation.
RESUMEN
In this study, a chlorine dioxide solution (UC-1) composed of chlorine dioxide was produced using an electrolytic method and subsequently purified using a membrane. UC-1 was determined to contain 2000 ppm of gaseous chlorine dioxide in water. The efficacy and safety of UC-1 were evaluated. The antimicrobial activity was more than 98.2% reduction when UC-1 concentrations were 5 and 20 ppm for bacteria and fungi, respectively. The half maximal inhibitory concentrations (IC50) of H1N1, influenza virus B/TW/71718/04, and EV71 were 84.65 ± 0.64, 95.91 ± 11.61, and 46.39 ± 1.97 ppm, respectively. A 3-(4,5-Dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) test revealed that the cell viability of mouse lung fibroblast L929 cells was 93.7% at a 200 ppm UC-1 concentration that is over that anticipated in routine use. Moreover, 50 ppm UC-1 showed no significant symptoms in a rabbit ocular irritation test. In an inhalation toxicity test, treatment with 20 ppm UC-1 for 24 h showed no abnormality and no mortality in clinical symptoms and normal functioning of the lung and other organs. A ClO2 concentration of up to 40 ppm in drinking water did not show any toxicity in a subchronic oral toxicity test. Herein, UC-1 showed favorable disinfection activity and a higher safety profile tendency than in previous reports.